OXYGENTAPH

Oxygenta Pharmaceutical Ltd.

BSE: 524636

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

46.07-0.9 (-1.98%)

23 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

0.5 / 100

Value Score

16.5 / 100

Price Momentum Score

38.2 / 100

QVM Score

4.8 / 100

Key Metrics

Market Cap

163.48

P/E (TTM)

P/B

P/S (TTM)

1.21

EV/EBITDA

CAPE (5Y)

ROE (TTM)

ROCE (TTM)

-33.99

ROA (TTM)

-17.30

Avg 3Y ROE

Earnings 3Y CAGR

24.73

Sales 3Y CAGR

66.99

Sales 5Y CAGR

13.82

Debt/Equity

Consensus TP

Strong Buy %

Promoter Holding

56.54

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Oxygenta Pharmaceutical Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -8.31% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Company's earnings are of low quality

Earnings quality score of 29.7 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

29.7 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Oxygenta Pharmaceutical Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

Not enough data

EBITDA FY

Oxygenta Pharmaceutical Ltd. Shareholding Pattern

Quarterly breakdown of Oxygenta Pharmaceutical Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	17.17	17.17	17.17	17.17	17.17	17.17	12.33	12.33	12.33	12.33	12.33	12.33	8.99	26.80	29.73	29.73	29.73	33.69	53.28	51.12	51.12	57.95	57.95	55.93	56.54	56.54	56.54
Indian Promoter	15.70	15.70	15.70	15.70	15.70	15.70	11.28	11.28	11.28	11.28	11.28	11.28	8.99	26.80	29.73	29.73	29.73	33.69	53.28	51.12	51.12	57.95	57.95	55.93	56.54	56.54	56.54
Foreign Promoter	1.47	1.47	1.47	1.47	1.47	1.47	1.06	1.06	1.06	1.06	1.06	1.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.10	0.10	0.10	0.10	0.10	0.10	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Mutual Funds / UTI	0.10	0.10	0.10	0.10	0.10	0.10	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	82.73	82.73	82.73	82.73	82.73	82.73	87.60	87.60	87.60	87.60	87.60	87.60	90.94	73.18	70.25	70.25	70.25	66.29	46.69	48.85	48.85	42.02	42.02	44.04	43.44	43.44	43.44
Bodies Corporate	1.68	1.68	1.66	1.59	1.58	1.54	25.70	1.01	25.67	25.66	25.65	25.65	25.76	10.92	11.82	12.28	12.12	11.43	0.34	0.31	0.31	0.26	0.29	0.34	0.40	0.42	0.40
Others (incl. Retail) No. of shareholders	81.05 8,641	81.05 8,641	81.07 8,643	81.14 8,651	81.15 8,651	81.19 8,652	61.90 8,650	86.59 8,772	61.93 8,936	61.94 8,901	61.95 8,898	61.95 9,000	65.18 8,898	62.26 8,887	58.43 8,874	57.97 8,953	58.13 10,006	54.86 9,875	46.35 10,055	48.54 10,007	48.54 9,930	41.76 10,015	41.73 10,098	43.70 10,139	43.04 10,113	43.02 10,104	43.04 10,188

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Oxygenta Pharmaceutical Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Virupaksha Organics Limited Promoter	February-2026	Market Purchase (Acquisition) 13th Feb 2026	55.90 %	₹ 46.60	2.24 lac	₹ 1.04 cr
Virupaksha Organics Limited Promoter	December-2025	Market Purchase (Acquisition) 17th Dec 2025	55.37 %	₹ 54.57	1.96 lac	₹ 1.07 cr
M V S Prasad Reddy Promoter	December-2024	Off Market (Acquisition) 13th Dec 2024	4.79 %	₹ 15.00	69.53 lac	₹ 10.43 cr
M V S Prasad Reddy Promoter	December-2024	Off Market (Acquisition) 13th Dec 2024	4.79 %	₹ 15.00	69.53 lac	₹ 10.43 cr
M V S Prasad Reddy Promoter	December-2024	Off Market (Acquisition) 13th Dec 2024	24.39 %	₹ 15.00	8.00 lac	₹ 1.20 cr
M V S Prasad Reddy Promoter	December-2024	Off Market (Acquisition) 13th Dec 2024	24.39 %	₹ 15.00	8.00 lac	₹ 1.20 cr
Raghavender Rao Kanuganti Promoter	December-2024	Off Market (Disposal) 13th Dec 2024	2.25 %	₹ 15.00	8.00 lac	₹ 1.20 cr

No corporate action data available.

Company Profile

Overview of Oxygenta Pharmaceutical Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulation...

Key personnel

Mr. Prasad Reddy Battinapatla

Chief Financial Officer

Ms. Kumkum Bajaj

Compliance Officer, Company Secretary

Dr. Sai Sudhakar VankineniD

Chairman of the Board

Mr. Amireddy Venkatesu ReddyD

Additional Executive Director

Mr. Chandra Mouliswar Reddy GangavaramD

Executive Director

Mr. Balasubba Reddy MamillaD

Executive Director

Mrs. Vedavathi GangavaramD

Non-Executive Director

Mr. Veera Reddy AravaD

Non-Executive Independent Director

View all

Incorporated on

27 Nov 1990

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

170

IPO date

25 Jul 1994

Free Float

69,83,545

Website

https://oxygentapharma.com

Phone no.

+914023543690

Address

Level-1 Plot No B1 and B2, IDA Gandhi Nagar Balanagar Township, Rangareddy, , 500037, India

Frequently Asked Questions

What is the current share price of Oxygenta Pharmaceutical Ltd.?

The current share price of Oxygenta Pharmaceutical Ltd. is ₹ 46.07 as of 23 Oct 2026.

What is the market capitalisation of Oxygenta Pharmaceutical Ltd.?

The market capitalisation of Oxygenta Pharmaceutical Ltd. stands at ₹ 163.48 Cr.

What is the PE ratio of Oxygenta Pharmaceutical Ltd.?

The Price-to-Earnings (PE) ratio of Oxygenta Pharmaceutical Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Oxygenta Pharmaceutical Ltd.?

Oxygenta Pharmaceutical Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of -33.99% as per the latest financial reports.

What is the 52-week high and low of Oxygenta Pharmaceutical Ltd.?

The 52-week high of Oxygenta Pharmaceutical Ltd. is - and the 52-week low is -.

What is the dividend yield of Oxygenta Pharmaceutical Ltd.?

The dividend yield of Oxygenta Pharmaceutical Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Oxygenta Pharmaceutical Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.03% and retail/public investors hold 43.04% of Oxygenta Pharmaceutical Ltd. shares.

What sector does Oxygenta Pharmaceutical Ltd. belong to?

Oxygenta Pharmaceutical Ltd. operates in the Healthcare sector.

What is the beta of Oxygenta Pharmaceutical Ltd.?

The beta of Oxygenta Pharmaceutical Ltd. is 0.96, indicating its price volatility relative to the broader market. Over the past 1 year, Oxygenta Pharmaceutical Ltd. has delivered an absolute return of -22.99%.

What is the RSI of Oxygenta Pharmaceutical Ltd.?

The 14-day Relative Strength Index (RSI) of Oxygenta Pharmaceutical Ltd. is 33.47, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.